CIAM
IMNM icon

Caitong International Asset Management’s Immunome IMNM Stock Holding History

Caitong International Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.7K Sell
4,704
-8,159
-63% -$175K 0.01% 556
2026
Q1 		$281K Buy
12,863
+12,119
+1,629% +$270K 0.05% 304
2025
Q4 		$16K Buy
+744
New +$13.1K ﹤0.01% 1042
2025
Q3 		– Sell
-610
Closed -$5.67K – 2214
2025
Q2 		$5.67K Buy
610
+419
+219% +$3.44K ﹤0.01% 966
2025
Q1 		$1.28K Buy
191
+85
+80% +$816 ﹤0.01% 1498
2024
Q4 		$1.13K Buy
+106
New +$1.28K ﹤0.01% 1304

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Caitong International Asset Management's IMNM Position: Q2 2026 in Review

Caitong International Asset Management reduced its Immunome (IMNM) stake by 63% in Q2 2026, selling an estimated $175K and leaving 4,704 shares worth $99.7K. The position accounts for 0.01% of the portfolio, ranked #556.

Caitong International Asset Management first reported a position in IMNM in Q4 2024 and has held it in 6 quarters since. The position peaked at $281K in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Caitong International Asset Management held 4,704 shares of Immunome worth $99.7K as of Q2 2026.
  • Caitong International Asset Management sold 8,159 Immunome shares in Q2 2026, an estimated $175K.
  • Immunome made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #556 holding.
  • Caitong International Asset Management first reported a position in Immunome in Q4 2024 and has held it in 6 quarters since.
  • Caitong International Asset Management's Immunome position peaked at $281K in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.